Keywords: serono, poised, enter, multiple, sclerosis, fray, ares-serono

Serono Poised To Enter Multiple Sclerosis Fray

Article | 08 October 1997

Print This

Ares-Serono's interferon beta-1a product Rebif has become the first drugof this type to improve three key measures of activity ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in